Moneycontrol PRO

Ashwin Mohan

Deputy Editor - Deals

Moneycontrol

TPG and Temasek-backed Dr Agarwals Healthcare picks 5 i-banks, kicks off IPO to raise around Rs 3,000 crore

BUSINESS

TPG and Temasek-backed Dr Agarwals Healthcare picks 5 i-banks, kicks off IPO to raise around Rs 3,000 crore

Singapore investment giant Temasek and US private equity firm TPG Growth collectively hold a majority stake of around 60 percent in Dr Agarwals Health Care and have participated in two fund raising rounds since May 2022

Verlinvest explores selling part stake in Danone & Deepika Padukone backed Epigamia

BUSINESS

Verlinvest explores selling part stake in Danone & Deepika Padukone backed Epigamia

Launched in 2015, Mumbai-based Epigamia is present in segments ranging from yogurt, curd and beverages to milkshakes , smoothies and kheer

Manipal Hospitals enters final leg of Medica Synergie buyout for Rs 1,200 cr-Rs 1,400 cr

BUSINESS

Manipal Hospitals enters final leg of Medica Synergie buyout for Rs 1,200 cr-Rs 1,400 cr

In December 2021, Temasek's healthcare platform Sheares had acquired a majority position in Medica Synergie by purchasing the stake held by private equity firm Quadria Capital

Theobroma stake sale: ICICI Venture, promoters appoint Arpwood Capital; eye valuation of Rs 3,500 crore

BUSINESS

Theobroma stake sale: ICICI Venture, promoters appoint Arpwood Capital; eye valuation of Rs 3,500 crore

Theobroma was founded in 2004, when the first pastry store opened its doors in Colaba, Mumbai. Today, the firm is a popular pan-India patisserie and cafe chain

IndiGo co-founder Rakesh Gangwal looks to raise about $450 mn via block deal

BUSINESS

IndiGo co-founder Rakesh Gangwal looks to raise about $450 mn via block deal

The floor price for the block deal is set at Rs 2,925 per share, which is about 5.8 percent discount to closing price.

Rajiv Jain’s GQG Partners ups the ante in India with bets on Bharti Airtel, Lodha

BUSINESS

Rajiv Jain’s GQG Partners ups the ante in India with bets on Bharti Airtel, Lodha

The investment firm manages more than $127 billion in assets globally.

Apax Partners-promoted Healthium Medtech on sale: EQT, KKR, Bain Cap, Advent likely bidders

BUSINESS

Apax Partners-promoted Healthium Medtech on sale: EQT, KKR, Bain Cap, Advent likely bidders

In 2018, British private equity firm Apax Partners acquired Bengaluru based Healthium Medtech (earlier known as Sutures India Pvt Ltd) from investors including TPG Growth and CX Partners

Exclusive: M&M promoter entity looking to sell stake worth $215 mn via block deal

BUSINESS

Exclusive: M&M promoter entity looking to sell stake worth $215 mn via block deal

"The block deal has been launched, and the offer price range is Rs 1911.5 per share to Rs 1970.65," said one of the people cited above, requesting anonymity.

EY Financial Services spearhead and veteran dealmaker Abizer Diwanji steps down

BUSINESS

EY Financial Services spearhead and veteran dealmaker Abizer Diwanji steps down

Diwanji has 26 years of experience in the financial services industry. Prior to EY, he spent nearly 15 years at rival Big 4 firm KPMG, where he started the restructuring practice in India

Exclusive: Macrotech Developers launches QIP to raise around $400 mn

BUSINESS

Exclusive: Macrotech Developers launches QIP to raise around $400 mn

The QIP has been launched and the proceeds will be used for acquisition of land and for debt repayment, sources told Moneycontrol

Aditya Birla Group taps Citi, BofA Securities and Morgan Stanley for Novelis US IPO

BUSINESS

Aditya Birla Group taps Citi, BofA Securities and Morgan Stanley for Novelis US IPO

Novelis US IPO: The deal is arguably the first instance of an Indian conglomerate attempting a listing of its subsidiary in the US market. In 2019, Bharti Airtel's Africa subsidiary had listed on the London Stock Exchange and the Nigerian Stock Exchange.

Gujarat Titans, HealthCare Global backer CVC raises $6.8 bn for largest Asia fund

BUSINESS

Gujarat Titans, HealthCare Global backer CVC raises $6.8 bn for largest Asia fund

CVC has been active in Asia since 1999 and has made more than 80 acquisitions in the region. Its India portfolio includes chemicals firm Sajjan India and UnitedLex, a legal services provider

KKR revives process to exit Avendus Capital; onboards Nomura as advisor

BUSINESS

KKR revives process to exit Avendus Capital; onboards Nomura as advisor

In November 2015, KKR picked up a controlling stake in Avendus Capital from existing investors

Whirlpool promoter entity plans to sell up to 24% stake worth $451 million

BUSINESS

Whirlpool promoter entity plans to sell up to 24% stake worth $451 million

On November 30, 2023, Whirpool Corp, the promoter group that currently owns 75 percent, said it would sell up to 24 percent of its ownership interest in Whirlpool of India Ltd in an effort to reduce debt levels

Belgian investor Verlinvest eyeing exit from Sula Vineyards

BUSINESS

Belgian investor Verlinvest eyeing exit from Sula Vineyards

Size of the proposed block deal by Verlinvest is around $52 million and the floor price is Rs 570/share

Hyundai picks JP Morgan, Citi and HSBC as advisors for mega IPO of India arm

BUSINESS

Hyundai picks JP Morgan, Citi and HSBC as advisors for mega IPO of India arm

A potential filing of the draft papers of this mega deal in the works is likely by June 2024 and if the listing plans fructify, it would be the biggest ever IPO on the Indian bourses.

Will India appeal to listing plans of big global brands? Yes, says Citi Asia's Udhay Furtado

BUSINESS

Will India appeal to listing plans of big global brands? Yes, says Citi Asia's Udhay Furtado

Furtado, the Co-Head, Asia ECM (Equity Capital Markets) at Citi believes India's attractiveness as a listing destination has increased with global supply chains in certain market segments moving into the country

Expect India to be busiest Asian market for IPOs in 2024 with bigger deals: Citi Asia's Udhay Furtado

BUSINESS

Expect India to be busiest Asian market for IPOs in 2024 with bigger deals: Citi Asia's Udhay Furtado

In 2023, the Indian arm of the investment bank worked on deals like the blockbuster $365-million Tata Technologies IPO, the $630-million Cube Highways InvIT listing and the $280-million Brookfield India REIT QIP

Advent kickstarts merger process of Suven Pharma & Cohance; engages Kotak & Citi

BUSINESS

Advent kickstarts merger process of Suven Pharma & Cohance; engages Kotak & Citi

Suven Pharmaceuticals is a listed CDMO and Cohance Lifesciences is an unlisted API and CDMO platform. Both are part of private equity firm Advent International's India portfolio.

Mankind Pharma promoters to divest part stake to meet Sebi's MPS norms

BUSINESS

Mankind Pharma promoters to divest part stake to meet Sebi's MPS norms

As per market regulator Sebi's guidelines, all listed firms should maintain a minimum public shareholding of 25 percent.

Citi's equity capital market deals spearhead Arvind Vashistha quits; may join rival JPM

BUSINESS

Citi's equity capital market deals spearhead Arvind Vashistha quits; may join rival JPM

Vashistha, a chartered accountant, joined Citi as head of equity capital markets in November 2014. He had joined from UBS, where has working as executive director, global capital markets, since 2006.

Brookfield Asset Management appoints Anuj Ranjan as new CEO of private equity business

BUSINESS

Brookfield Asset Management appoints Anuj Ranjan as new CEO of private equity business

Before this elevation, Ranjan was President of Brookfield’s Private Equity business and Global Head of Business Development

Aadhar Housing Finance refiles draft papers for Rs 5,000 crore IPO

BUSINESS

Aadhar Housing Finance refiles draft papers for Rs 5,000 crore IPO

Aadhar Housing Finance had previously filed papers for an IPO in January 2021 and had received a nod from the regulator in May 2022.

Impact of tax breather in Budget 2024 for sovereign wealth funds and pension funds

BUSINESS

Impact of tax breather in Budget 2024 for sovereign wealth funds and pension funds

Experts believe the one-year extension of tax sops will aid the National Monetisation Pipeline and also add more sovereign wealth funds and pension funds to the India infrastructure story

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347